I

Innova Captab Ltd
NSE:INNOVACAP

Watchlist Manager
Innova Captab Ltd
NSE:INNOVACAP
Watchlist
Price: 1 015.35 INR 4.81% Market Closed
Market Cap: 58.1B INR
Have any thoughts about
Innova Captab Ltd?
Write Note

Innova Captab Ltd
Other Long-Term Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Innova Captab Ltd
Other Long-Term Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Long-Term Assets CAGR 3Y CAGR 5Y CAGR 10Y
I
Innova Captab Ltd
NSE:INNOVACAP
Other Long-Term Assets
â‚ą417.2m
CAGR 3-Years
54%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Divi's Laboratories Ltd
NSE:DIVISLAB
Other Long-Term Assets
â‚ą680m
CAGR 3-Years
4%
CAGR 5-Years
-14%
CAGR 10-Years
N/A
Suven Life Sciences Ltd
NSE:SUVEN
Other Long-Term Assets
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Dishman Carbogen Amcis Ltd
NSE:DCAL
Other Long-Term Assets
â‚ą156.3m
CAGR 3-Years
-58%
CAGR 5-Years
-41%
CAGR 10-Years
N/A
Syngene International Ltd
NSE:SYNGENE
Other Long-Term Assets
â‚ą2.1B
CAGR 3-Years
6%
CAGR 5-Years
4%
CAGR 10-Years
N/A
Tarsons Products Ltd
NSE:TARSONS
Other Long-Term Assets
â‚ą1.3B
CAGR 3-Years
53%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Innova Captab Ltd
Glance View

Market Cap
58.1B INR
Industry
Life Sciences Tools & Services

Innova Captab Ltd is a IN-based company operating in Life Sciences Tools & Services industry. The company is headquartered in Panchkula, Haryana. The company went IPO on 2023-12-29. Innova Captab Ltd is an integrated pharmaceutical company. The firm is engaged in the business of manufacturing and trading of drugs and pharmaceuticals. The company has presence across the pharmaceuticals value chain, including research and development, manufacturing, drug distribution and marketing and exports. Its business includes CDMO business, domestic branded generics business, and international branded generic product business. Its CDMO business provides research, product development and manufacturing services. Its branded generics business consists of the development, manufacture and distribution of generic formulation products, which are marketed and distributed in India under its own brand names through online and offline channels. Its generic drug products are also available online through various e-commerce pharmacy sites. The company has developed a diversified branded generics product portfolio including Tablets, capsules, dry syrups, dry powder injection, ointments and liquid orals.

INNOVACAP Intrinsic Value
779.06 INR
Overvaluation 23%
Intrinsic Value
Price
I

See Also

What is Innova Captab Ltd's Other Long-Term Assets?
Other Long-Term Assets
417.2m INR

Based on the financial report for Mar 31, 2024, Innova Captab Ltd's Other Long-Term Assets amounts to 417.2m INR.

What is Innova Captab Ltd's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 3Y
54%

Over the last year, the Other Long-Term Assets growth was -26%. The average annual Other Long-Term Assets growth rates for Innova Captab Ltd have been 54% over the past three years .

Back to Top